Enveric Biosciences Inc (NASDAQ:ENVB) traded at $1.19 at close of the session on Tuesday, March 19, made an upward move of 8.18% on its previous day’s price.
Looking at the stock we see that its previous close was $1.10 and the beta (5Y monthly) reads 0.64 . In terms of its 52-week price range, ENVB has a high of $6.98 and a low of $0.65. The company’s stock has gained about 43.20% over that past 30 days.
Enveric Biosciences Inc has a market cap of $6.70 million and is expected to release its quarterly earnings report on Mar 29, 2024 – Apr 02, 2024. Estimates by analysts give the company expected earnings per share (EPS) of -$1.54, with the EPS growth for the year raised at -$8.17 for 2023 and -$2.65 for next year. These figures represent 37.20% and 67.60% growth in EPS for the two years respectively.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the ENVB stock, short term indicators assign the stock an average of Hold, while medium term indicators assign it an average of 50% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Looking further, we note the current price level is 1.64% off its SMA20 and 13.03% from its 50-day simple moving average. The RSI (14) is pointing at 51.99 while the volatility over the past week is 21.52% and jumps to 22.83% over the past one month. The beta value is 0.87, while the average true range (ATR) is currently pointing at 0.26.
Coming back to Enveric Biosciences Inc (NASDAQ:ENVB), we note that the average 3-month trading volume was 3.54 million, while that of the preceding 10-day period stands at 0.38 million. Current shares outstanding are 5.63 million.
The insiders hold 17.28% of the company’s shares while institutions hold 8.70%. The data shows that short shares as of Feb 29, 2024, stood at 95060.0 at a short ratio of 0.01. This represents a 3.47% short interest in shares outstanding on Feb 29, 2024. Shares short rose in February from the previous month at 22950.0. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -8.46% down in year-to-date price movement.
